Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Vycor Medical (VYCO) Cost of Revenue (2016 - 2025)

Vycor Medical has reported Cost of Revenue over the past 16 years, most recently at $81507.0 for Q4 2025.

  • Quarterly Cost of Revenue rose 40.91% to $81507.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $302293.0 through Dec 2025, up 81.22% year-over-year, with the annual reading at $302293.0 for FY2025, 81.22% up from the prior year.
  • Cost of Revenue was $81507.0 for Q4 2025 at Vycor Medical, up from $61860.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $81507.0 in Q4 2025 and troughed at $27885.0 in Q2 2022.
  • The 5-year median for Cost of Revenue is $37078.5 (2022), against an average of $44471.2.
  • Year-over-year, Cost of Revenue dropped 29.1% in 2022 and then surged 130.59% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $31778.0 in 2021, then grew by 16.91% to $37151.0 in 2022, then increased by 13.11% to $42020.0 in 2023, then skyrocketed by 37.66% to $57844.0 in 2024, then soared by 40.91% to $81507.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Cost of Revenue are $81507.0 (Q4 2025), $61860.0 (Q3 2025), and $81082.0 (Q2 2025).